Results 111 to 120 of about 694,423 (327)
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis [PDF]
, 2016 Background Non-absorbable disaccharides (lactulose and lactitol) are recommended as first-line treatment for hepatic encephalopathy. The previous (second) version of this review included 10 randomised clinical trials (RCTs) evaluating non-absorbable ...
Gluud, LL, Morgan, MY, Vilstrup, H
core
Microbiome Therapeutics for Hepatic Encephalopathy.
Journal of Hepatology, 2021 P. Bloom, E. Tapper, V. Young, A. Lok
semanticscholar +1 more source
Особливості діагностики енцефалопатії у хворих з синдромом портальної гіпертензії [PDF]
, 2017 Актуальність. Печінкова енцефалопатія — патологічні зміни функцій головного мозку незапального генезу, що проявляються синдромом вторинних неврологічних і когнітивних розладів, спричинених комплексом глибоких метаболічних порушень, в результаті гострої ...
Меланіч, С.Л. +2 more
core
Portal Hypertension &Cirrhosis, EarlyView.The challenge of transjugular intrahepatic portosystemic shunt (TIPS) remains the puncture of the portal vein. Establishing an optimal shunt position in the left branch of the portal vein would be a better option for reducing the risk of postoperative hepatic encephalopathy and stent dysfunction.
Yi‐Han Yang +6 more
wiley +1 more source
The neurogliovascular unit in hepatic encephalopathy
JHEP Reports, 2021 Wouter Claeys +9 more
semanticscholar +1 more source
Portal Hypertension &Cirrhosis, EarlyView.Gastroesophageal variceal bleeding is a serious complication of compensated advanced chronic liver disease (cACLD) with high mortality. This study developed a deep learning‐based model integrating two‐dimensional shear wave elastography (2D‐SWE) imaging of the liver and spleen with clinical data to predict gastroesophageal varices (GEV) and high‐risk ...
Lan Wang +50 more
wiley +1 more source
Hepatic encephalopathy : a new perspective for therapy [PDF]
, 1979 P.B. Soeters
openalex +1 more source
Portal Hypertension &Cirrhosis, EarlyView.Acute‐on‐chronic liver failure (ACLF) is a life‐threatening syndrome with an extremely poor prognosis that may arise from compensated liver disease. This meta‐analysis systematically delineates the epidemiological features of ACLF among patients with compensated liver disease, revealing marked regional heterogeneity and temporal trends.
Lei Liu +9 more
wiley +1 more source
State‐of‐the‐Art on Model‐Informed Drug Development Approaches for Pediatric Rare Diseases
CPT: Pharmacometrics &Systems Pharmacology, EarlyView.ABSTRACT Pediatric rare diseases present unique challenges for drug development due to small patient populations, ethical constraints on clinical trial design, and limited prospectively defined natural history data. Model‐Informed Drug Development (MIDD) has emerged as a powerful paradigm to address these challenges by leveraging quantitative methods ...
Rajesh Krishna +4 more
wiley +1 more source
Therapeutic efficacy of l-ornithine l-aspartate in patients with hepatic encephalopathy [PDF]
, 2015 To determine the efficacy of ornithine-aspartate in reducing blood ammonia levels and clinical improvement, as a part of treatment in hepatic encephalopathy. Material & method: A randomized placebo controlled trial was conducted in 2013 in Jinnah medical
Aidrus, Fadieleh +4 more
core +1 more source